ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,794Medicare Part D Prescriptions Filled, Including Refills

Rank: 114 out of 337

$248K Total Retail Price of All Prescriptions

Rank: 186 out of 337

490 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 490 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 6,961 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

10% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$32 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 536 484 1 1
LISINOPRIL 504 490 2 2
LEVOTHYROXINE SODIUM 345 330 3 5
ATENOLOL 255 247 4 10
HYDROCHLOROTHIAZIDE 233 233 5 9
METFORMIN HCL 224 207 6 12
LOVASTATIN 211 193 7 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 206 180 8 31
PRAVASTATIN SODIUM 205 185 9 14
CITALOPRAM HBR 200 189 10 17
OMEPRAZOLE 197 156 11 4
METOPROLOL TARTRATE 192 153 12 6
FUROSEMIDE 184 156 13 8
ATORVASTATIN CALCIUM 153 127 14 7
AMLODIPINE BESYLATE 150 149 15 3
TRAZODONE HCL 125 106 16 16
SERTRALINE HCL 119 97 17 18
HYDROCODONE-ACETAMINOPHEN 109 102 S3 18 13
ALPRAZOLAM 108 101 19 78
LOSARTAN POTASSIUM 106 93 20 15
PREDNISONE 92 83 21 40
FINASTERIDE 85 83 22 83
ALENDRONATE SODIUM 84 84 23 19
LOSARTAN-HYDROCHLOROTHIAZIDE 84 68 23 60
RANITIDINE HCL 82 41 25 30
DOXYCYCLINE HYCLATE 82 68 25 252
LIPITOR 79 73 27 33
GLYBURIDE-METFORMIN HCL 70 65 R 28 99
CLOPIDOGREL 70 63 28 42
CIPROFLOXACIN HCL 67 62 30 71
METOPROLOL SUCCINATE 66 47 31 21
PAROXETINE HCL 64 45 32 46
ATENOLOL-CHLORTHALIDONE 64 63 32 148
FLUTICASONE PROPIONATE 64 52 32 34
TAMSULOSIN HCL 61 61 35 25
VENLAFAXINE HCL ER 60 52 36 86
DOXAZOSIN MESYLATE 56 46 37 68
TRIAMTERENE-HCTZ 53 53 38 39
ALLOPURINOL 52 43 39 28
KLOR-CON M20 51 45 40 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.